Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00831623 · ClinicalTrials.gov registry record · NA
Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer
A NA study of Prostate Cancer, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 167
- Enrollment target
- 1
- Study location
NCT00831623 is a NA study of Prostate Cancer that has completed, run by Loma Linda University. The registered enrollment target is 167 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00831623, a NA study of Prostate Cancer, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine hypofractionated conformal proton beam radiation therapy of prostate cancer can achieve similar treatment benefits as our current institutional standard with conventional fractionation.
Conditions Studied
Interventions
- RADIATION Proton Radiation
- RADIATION Proton
Study Locations (1)
California
- Loma Linda University Medical Center / James M. Slater Proton Treatment Center - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2009-02-17 |
| Est. Completion | 2019-07-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00831623
The ClinicalTrials.gov registry entry for NCT00831623 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (73% lower). The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Proton Radiation is the first listed.
NCT00831623 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00831623 about?
NCT00831623 is a clinical study titled "Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer". The purpose of this study is to determine hypofractionated conformal proton beam radiation therapy of prostate cancer can achieve similar treatment benefits as our current institutional standard with conventional fractionation.
What is the current status of trial NCT00831623?
This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2009-02-17. Estimated completion is 2019-07-18.
What conditions does trial NCT00831623 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT00831623?
The interventions under investigation include: Proton Radiation (RADIATION), Proton (RADIATION).
Who is sponsoring clinical trial NCT00831623?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00831623 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.